Borealis inaugurates new catalyst plant in Austria
Based on the company’s proprietary revolutionary catalyst technology, the new plant will be used to develop new types of catalysts as well as improve processes for catalyst production.
Vertex Pharmaceuticals and Genomics have agreed a four-year extension to their drug discovery partnership in a deal with a potential value exceeding $220m.